Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma.

Twenty patients with epithelial ovarian carcinoma were treated with high-dose cisplatin 200mg m-2. Patients were to receive three cycles at 21 day intervals. Treatment was stopped if severe myelosuppression or any neurotoxicity occurred. Overall, eight (40%) of patients responded with a complete res...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kehoe, S., Redman, C., Varma, R., Buxton, J., Luesley, D., Blackledge, G., Stanley, A.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1992
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977413/
https://ncbi.nlm.nih.gov/pubmed/1419613
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires